Article Data

  • Views 739
  • Dowloads 108

Case Reports

Open Access

Mitotically active cellular fibroma of the ovary: a case report and a review of the literature

  • H. Wu1
  • J. Xie1
  • W. Huang2
  • J. Wu3,*,

1Department of Gynaecology, Nanjing Medical University Affiliated Nanjing Hospital (Nanjing First Hospital), Nanjing

2Department of Pathology, Nanjing Medical University Affiliated Nanjing Hospital (Nanjing First Hospital), Nanjing

3Department of Obstetrics and Gynecology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, (P.R. China)

DOI: 10.12892/ejgo23802014 Vol.35,Issue 1,January 2014 pp.81-83

Published: 10 January 2014

*Corresponding Author(s): J. Wu E-mail: drwuhui@hotmail.com

Abstract

Mitotically active cellular fibroma (MACF) is characterized by increased cellularity, mitotic activity, and less frequently, nuclear atypia, which comprises 10% of ovarian fibromatous tumors. The authors report the case of a 76-year-old woman who presented at the present hospital with a two-month pelvic mass. B ultrasound disclosed a 75 × 52 × 41 mm mass in the right accessories. A hysterectomy and bilateral salpingo-oophorectomy was performed. Histologically, the tumor was composed of a densely cellular proliferation of fibrolastic-like cells with bland nuclear features and arranged in a fascicular pattern. There were more than four mitotic figures per ten high-power fields (HPFs). The histological diagnosis for the mass of the right ovary was MACF. MACF should be distinguished from ovarian fibrosarcoma. MACF is a recent histopathologic entity. Despite the high count of mitotic figures, the clinical course of the tumor is typically uneventful. Long-term clinical follow-up is recommended.


Keywords

Ovary; fibroma; Mitotically active cellular fibroma; Outcome.


Cite and Share

H. Wu,J. Xie,W. Huang,J. Wu. Mitotically active cellular fibroma of the ovary: a case report and a review of the literature. European Journal of Gynaecological Oncology. 2014. 35(1);81-83.

References

[1] Irving J.A., McCluggage W.G.: “Ovarian spindle cell lesions: a review with emphasis on recent developments and differential diagnosis”. Adv. Anat. Pathol., 2007, 14, 305.

[2] Irving J. A., Alkushi A., Young R. H., Clement P. B.: “Cellular fibroma of the ovary. A study of 75 cases including 40 mitotically active tumors emphasizing their distinction from fibrosarcoma”. Am. J. Surg. Pathol., 2006, 30, 929.

[3] Kaku S., Takeshima N., Akiyama F., Furuta R., Hirai Y., Takizawa K.: “A unique fibrous tumor of the ovary. Fibrosarcoma or mitotically active cellular fibroma?”. Anticancer. Res., 2007, 27, 4365.

[4] Bucella D., Limbosch J., Buxant F., Simon P., Fayt I., Anaf V., No l JC.: “Recurrence of mitotically active cellular fibroma of the ovary”. Obstet. Gynecol. Int., 2009, 2009, 803062. doi: 10.1155/2009/803062. Epub 2009 Jan 12.

[5] Monterio S.B., Costa A., Paiva V.: “ Mitotically active cellular ovarian fibroma with Meigs syndrome and elevated CA-125. Towards fertility preservation”. Pediatr. Adolesc. Gynecol., 2012, 25, e107.

[6] Prat J., Scully R. E.: “Cellular fibromas and fibrosarcomas of the ovary: a comparative clinicopathologic analysis of seventeen cases”. Cancer, 1981, 47, 2663.

[7] Tsuji T., Kawauchi S., Utsunomiya T., Nagata Y., Tsuneyoshi M.: “ Fibrosarcoma versus cellular fibroma of the ovary: a comparative study of their proliferative activity and chromosome aberrations using MIB-1 immunostaining, DNA flow cytometry, and fluores-cence in situ hybridization”. Am. J. Surg. Pathol., 1997, 21, 52.

[8] Huang Y. C., Hsu K. F., Chou C. Y., Dai Y. C., Tzeng C. C.: “Ovarian fibrosarcoma with long-term survival: a case report”. Int. J. Gynecol. Cancer., 2001, 11, 331.

[9] Cinel L., Taner D., Nabaei S. B., Oquz S., Gökmen O.: “Ovarian fibrosarcoma with five-year survival: a case report”. Eur. J. Gynaecol. Oncol., 2002, 23, 345.

[10] Choi W. J., Ha M. T., Shin J. K., Lee J. H.: “Primary ovarian fibrosarcoma with long-term survival: a report of two cases”. J. Obstet. Gynaecol. Res., 2006, 32, 524.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top